These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9773792)

  • 1. Factors relating to urinary protein excretion in children with autosomal dominant polycystic kidney disease.
    Sharp C; Johnson A; Gabow P
    J Am Soc Nephrol; 1998 Oct; 9(10):1908-14. PubMed ID: 9773792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overt proteinuria and microalbuminuria in autosomal dominant polycystic kidney disease.
    Chapman AB; Johnson AM; Gabow PA; Schrier RW
    J Am Soc Nephrol; 1994 Dec; 5(6):1349-54. PubMed ID: 7894001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteinuria in children with autosomal dominant polycystic kidney disease.
    Seeman T; Pohl M; John U
    Minerva Pediatr; 2018 Oct; 70(5):413-417. PubMed ID: 30302987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of urinary biomarkers with disease severity in patients with autosomal dominant polycystic kidney disease: a cross-sectional analysis.
    Meijer E; Boertien WE; Nauta FL; Bakker SJ; van Oeveren W; Rook M; van der Jagt EJ; van Goor H; Peters DJ; Navis G; de Jong PE; Gansevoort RT
    Am J Kidney Dis; 2010 Nov; 56(5):883-95. PubMed ID: 20888104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of antihypertensive therapy on renal function and urinary albumin excretion in hypertensive patients with autosomal dominant polycystic kidney disease.
    Ecder T; Chapman AB; Brosnahan GM; Edelstein CL; Johnson AM; Schrier RW
    Am J Kidney Dis; 2000 Mar; 35(3):427-32. PubMed ID: 10692268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Sirolimus on Disease Progression in Patients with Autosomal Dominant Polycystic Kidney Disease and CKD Stages 3b-4.
    Ruggenenti P; Gentile G; Perico N; Perna A; Barcella L; Trillini M; Cortinovis M; Ferrer Siles CP; Reyes Loaeza JA; Aparicio MC; Fasolini G; Gaspari F; Martinetti D; Carrara F; Rubis N; Prandini S; Caroli A; Sharma K; Antiga L; Remuzzi A; Remuzzi G;
    Clin J Am Soc Nephrol; 2016 May; 11(5):785-794. PubMed ID: 26912555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Blood pressure, functional and morphological study of kidneys in children with autosomal dominant polycystic kidney disease].
    Seeman T; Vondrichová H; Strízová J; Sikut M; Janda J; Schärer K
    Cas Lek Cesk; 1999 Mar; 138(6):178-84. PubMed ID: 10510532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid Progression of Autosomal Dominant Polycystic Kidney Disease: Urinary Biomarkers as Predictors.
    Messchendorp AL; Meijer E; Visser FW; Engels GE; Kappert P; Losekoot M; Peters DJM; Gansevoort RT;
    Am J Nephrol; 2019; 50(5):375-385. PubMed ID: 31600749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary excretion of monocyte chemoattractant protein-1 in autosomal dominant polycystic kidney disease.
    Zheng D; Wolfe M; Cowley BD; Wallace DP; Yamaguchi T; Grantham JJ
    J Am Soc Nephrol; 2003 Oct; 14(10):2588-95. PubMed ID: 14514736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors influencing progression of renal failure in autosomal dominant polycystic kidney disease.
    Choukroun G; Itakura Y; Albouze G; Christophe JL; Man NK; Grünfeld JP; Jungers P
    J Am Soc Nephrol; 1995 Dec; 6(6):1634-42. PubMed ID: 8749691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early renal abnormalities in children with postnatally diagnosed autosomal dominant polycystic kidney disease.
    Selistre L; de Souza V; Ranchin B; Hadj-Aissa A; Cochat P; Dubourg L
    Pediatr Nephrol; 2012 Sep; 27(9):1589-93. PubMed ID: 22689086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal volume and cardiovascular risk assessment in normotensive autosomal dominant polycystic kidney disease patients.
    Sans L; Pascual J; Radosevic A; Quintian C; Ble M; Molina L; Mojal S; Ballarin JA; Torra R; Fernández-Llama P
    Medicine (Baltimore); 2016 Dec; 95(49):e5595. PubMed ID: 27930582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of autosomal dominant polycystic kidney disease by NMR spectroscopic fingerprinting of urine.
    Gronwald W; Klein MS; Zeltner R; Schulze BD; Reinhold SW; Deutschmann M; Immervoll AK; Böger CA; Banas B; Eckardt KU; Oefner PJ
    Kidney Int; 2011 Jun; 79(11):1244-53. PubMed ID: 21389975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microalbuminuria in normotensive patients with autosomal-dominant polycystic kidney disease.
    Martinez-Vea A; Gutierrez C; Bardají A; Pastor R; García C; Peralta C; Richart C; Oliver JA
    Scand J Urol Nephrol; 1998 Sep; 32(5):356-9. PubMed ID: 9825400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early renal and vascular changes in ADPKD patients with low-grade albumin excretion and normal renal function.
    Azurmendi PJ; Fraga AR; Galan FM; Kotliar C; Arrizurieta EE; Valdez MG; Forcada PJ; Stefan JS; Martin RS
    Nephrol Dial Transplant; 2009 Aug; 24(8):2458-63. PubMed ID: 19332866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective change in renal volume and function in children with ADPKD.
    Cadnapaphornchai MA; McFann K; Strain JD; Masoumi A; Schrier RW
    Clin J Am Soc Nephrol; 2009 Apr; 4(4):820-9. PubMed ID: 19346430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in urinary albumin excretion, inflammatory and oxidative stress markers in ADPKD patients with hypertension.
    Nakamura T; Sato E; Fujiwara N; Kawagoe Y; Yamada S; Ueda Y; Koide H
    Am J Med Sci; 2012 Jan; 343(1):46-51. PubMed ID: 21760473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease.
    Zeltner R; Poliak R; Stiasny B; Schmieder RE; Schulze BD
    Nephrol Dial Transplant; 2008 Feb; 23(2):573-9. PubMed ID: 17984104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort.
    Chapman AB; Guay-Woodford LM; Grantham JJ; Torres VE; Bae KT; Baumgarten DA; Kenney PJ; King BF; Glockner JF; Wetzel LH; Brummer ME; O'Neill WC; Robbin ML; Bennett WM; Klahr S; Hirschman GH; Kimmel PL; Thompson PA; Miller JP;
    Kidney Int; 2003 Sep; 64(3):1035-45. PubMed ID: 12911554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic heterogeneity in pediatric autosomal dominant polycystic kidney disease at first presentation: a single-center, 20-year review.
    Tee JB; Acott PD; McLellan DH; Crocker JF
    Am J Kidney Dis; 2004 Feb; 43(2):296-303. PubMed ID: 14750095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.